IMBCAMS reveals Phase 2 clinical trial of COVID-19 vaccine in China

Date: 2020-06-22   Author: Saipriya Iyer  Category: #news

IMBCAMS reveals Phase 2 clinical trial of COVID-19 vaccine in China

The IMB (Institute of Medical Biology) at the CAMS (Chinese Academy of Medical Sciences) has recently stated that Chinese researchers have started the Phase 2 COVID-19 vaccine trial. The 2nd phase of this potential coronavirus vaccine has been commenced to examine its safety and effectiveness.

There are nearly a dozen COVID-19 vaccines that are currently under the human trial phase across the globe. The WHO (World Health Organization) has informed about the accelerating cases and impacts of the coronavirus pandemic, which has reshaped the global order and placed people at higher risks. In the wake of this pandemic, however, no vaccines have passed the late-stage, large scale Phase 3 clinical trial, the crucial step needed prior to getting the regulatory approval for selling the vaccine globally.

Among other researchers, the IMBCAMS has recently begun the Phase 2 human trial for the experimental study. The vaccine that is currently under trial is among the six vaccines that are being developed by the Chinese researchers against the COVID-19 vaccine.

The institute has reportedly stated that nearly 200 participants were included in the 1st phase of the vaccine trial that was conducted in May. This Phase 2 trial will target to emphasize on the immune responses among healthy patients while determining the dose of the vaccine. It also stated its aim to adopt a plant for producing the COVID-19 vaccine in 2020, which in turn, will help in preparing the future vaccine supplies in China.

According to Gao Fu, Director of China CDC (Chinese Center for Disease Control & Prevention), some groups of high-risk special needs patients can use the experimental vaccine under urgent circumstances by 2020 end.

The pandemic, which was discovered for the 1st time in late 2019, has impacted nearly 8.81 million and claimed the lives of over 460,000 people across the globe.

Source credit:

https://www.thehindubusinessline.com/news/world/china-begins-phase-2-of-the-clinical-trial-for-potential-covid-19-vaccine/article31882148.ece



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

63 moons to offer next-gen tech to Spuma SRL in pan-European market expansion

Author: Saipriya Iyer

63 moons technologies, a world leader in providing next-generation technology platforms, has recently announced its plans to boost and back Italy-located Spuma SRL, with its next-generation technological abilities and ...


Global Joint Reconstruction Devices Market to Observe Strong Development during the Forecast Period 2021 to 2027

Author: Rahul Varpe

Global market insights declares the publication of its latest research report, with the title ‘global Joint Reconstruction Devices market’. This report sheds light on the analysis of the industry chall...


Surgical Robots Market is poised to grow at a Healthy CAGR between 2022 to 2030

Author: Rahul Varpe

Global market insights declares the publication of its latest research report, with the title ‘global Surgical Robots market’. This report sheds light on the analysis of the industry challenges, growth opportunities, industry threats, ...